1. Home
  2. MDAI vs DARE Comparison

MDAI vs DARE Comparison

Compare MDAI & DARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MDAI

Spectral AI Inc.

HOLD

Current Price

$2.70

Market Cap

77.3M

Sector

Health Care

ML Signal

HOLD

Logo Dare Bioscience Inc.

DARE

Dare Bioscience Inc.

HOLD

Current Price

$2.38

Market Cap

35.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDAI
DARE
Founded
2013
2015
Country
United States
United States
Employees
65
24
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
77.3M
35.5M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
MDAI
DARE
Price
$2.70
$2.38
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$3.00
$10.00
AVG Volume (30 Days)
544.1K
769.5K
Earning Date
05-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,807,885.00
Revenue This Year
N/A
$2,115.12
Revenue Next Year
$23.50
$122.62
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.18
$1.27
52 Week High
$3.21
$9.19

Technical Indicators

Market Signals
Indicator
MDAI
DARE
Relative Strength Index (RSI) 70.51 48.90
Support Level $1.39 $1.79
Resistance Level $2.80 $2.54
Average True Range (ATR) 0.21 0.35
MACD 0.03 -0.07
Stochastic Oscillator 94.02 22.28

Price Performance

Historical Comparison
MDAI
DARE

About MDAI Spectral AI Inc.

Spectral AI Inc is an AI company focused on predictive medical diagnostics. Its DeepView System uses proprietary AI algorithms to distinguish between fully damaged, partially damaged and healthy human tissue characters invisible to the naked eye, at the initial time point of wound presentation. The DeepView System delivers a binary prediction on the wound's capacity to heal or not-heal by a specified time point in the future. The company focuses on the burn indication which is supported by the BARDA PBS contract.

About DARE Dare Bioscience Inc.

Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

Share on Social Networks: